Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Tay

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
The Oncologist|April 18, 2024
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple MyelomaHira Mian, Hsien Seow, Amaris K Balitsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority TrialJason Tay, David S Allan, Elizabeth Chatelain, et al.
Blood Cancer Journal|January 31, 2018
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizersAlissa Visram, Christopher Bredeson, David Allan, et al.
British Journal of Haematology|February 22, 2020
Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia veraHolly Lee, Sylvia McCulloch, Etienne Mahe, et al.
Leukemia & Lymphoma|June 11, 2014
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemiaAdam Bryant, Dawn Sheppard, Mitchell Sabloff, et al.
Annals of Hematology|August 26, 2022
Amyloidosis and COVID-19: experience from an amyloid program in CanadaEllen Lewis, Nowell Fine, Robert J H Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2015
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored ApproachDawn Sheppard, Jason Tay, Douglas Palmer, et al.
Transfusion|August 5, 2008
Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantationGurnaam Kasbia, Farjah Al-Gahtani, Jason Tay, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
JAMA Neurology|August 27, 2014
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant programSheilagh Sanders, Christopher Bredeson, C Elizabeth Pringle, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
The Oncologist|April 18, 2024
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple MyelomaHira Mian, Hsien Seow, Amaris K Balitsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2020
Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority TrialJason Tay, David S Allan, Elizabeth Chatelain, et al.
Blood Cancer Journal|January 31, 2018
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizersAlissa Visram, Christopher Bredeson, David Allan, et al.
British Journal of Haematology|February 22, 2020
Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia veraHolly Lee, Sylvia McCulloch, Etienne Mahe, et al.
Leukemia & Lymphoma|June 11, 2014
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemiaAdam Bryant, Dawn Sheppard, Mitchell Sabloff, et al.
Annals of Hematology|August 26, 2022
Amyloidosis and COVID-19: experience from an amyloid program in CanadaEllen Lewis, Nowell Fine, Robert J H Miller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 9, 2015
Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored ApproachDawn Sheppard, Jason Tay, Douglas Palmer, et al.
Transfusion|August 5, 2008
Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantationGurnaam Kasbia, Farjah Al-Gahtani, Jason Tay, et al.
Blood Advances|January 4, 2018
Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccinationKareem Jamani, Judy MacDonald, Martin Lavoie, et al.
JAMA Neurology|August 27, 2014
Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant programSheilagh Sanders, Christopher Bredeson, C Elizabeth Pringle, et al.
Pageof 9